2927 — AFC-HD AMS Life Science Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapNeutral

Annual cashflow statement for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st	2025 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2,158	1,235	1,546	1,911	2,201
Depreciation
Amortisation
Non-Cash Items	64	-238	102	80.9	344
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-288	-512	-1,767	-1,537	-2,072
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,583	1,492	865	1,540	1,854
Capital Expenditures	-492	-958	-1,940	-3,407	-3,606
Purchase of Fixed Assets
Other Investing Cash Flow Items	217	-120	-6.33	645	212
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-275	-1,078	-1,946	-2,761	-3,395
Financing Cash Flow Items	-58.8	-584	-52.7	-37.8	66.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,185	1,160	1,881	2,232	668
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,496	1,591	804	1,009	-871